OS Therapies Inc
OSTXNYSECIK 1795091HealthcareFiscal year ends Dec 31
Reports and events: 74 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1908:47 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-110497 |
| 2026-10-0516:37 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-106849 |
| 2026-09-1017:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-098880 |
| 2026-09-0916:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-098403 |
| 2026-08-2116:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-092651 |
| 2026-08-1417:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090238 |
| 2026-08-1216:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-088435 |
| 2026-08-0616:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-086150 |
| 2026-07-2917:00 ET | 8-K | 1.02 Termination of a material agreement | 0001213900-26-082876 |
| 2026-07-2416:16 ET | DEF 14A | Proxy statementPeriod 2026-09-09 | 0001213900-26-081390 |
| 2026-07-0709:18 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-075781 |
| 2026-07-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-075013 |
| 2026-05-1806:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-058070 |
| 2026-04-3016:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-050211 |
| 2026-04-0217:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-039529 |
| 2026-03-3116:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-037476 |
| 2026-03-3120:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-036629 |
| 2026-03-0616:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-024726 |
| 2026-02-1316:06 ET | 8-K | 8.01 Other events | 0001213900-26-016408 |
| 2026-01-1208:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-003166 |
| 2025-11-1416:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110829 |
| 2025-10-2116:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-100821 |
| 2025-10-1717:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-100019 |
| 2025-09-3016:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-093936 |
| 2025-09-0216:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-083396 |
| 2025-08-2606:15 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-080484 |
| 2025-08-2517:14 ET | DEF 14A | Proxy statementPeriod 2025-10-14 | 0001213900-25-080407 |
| 2025-08-1906:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-078152 |
| 2025-08-1821:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-024711 |
| 2025-08-1816:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-077916 |
| 2025-08-1516:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-077431 |
| 2025-08-0416:30 ET | S-1 | Registration statement | 0001213900-25-071368 |
| 2025-07-1408:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-063479 |
| 2025-06-2707:59 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001213900-25-058603 |
| 2025-06-2408:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-056911 |
| 2025-05-2316:51 ET | S-1 | Registration statement | 0001213900-25-047395 |
| 2025-05-1616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-044875 |
| 2025-05-1516:57 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-044336 |
| 2025-05-0921:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-009544 |
| 2025-04-1516:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-032071 |
| 2025-04-0917:29 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-030375 |
| 2025-04-0221:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-027522 |
| 2025-03-3116:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-026322 |
| 2025-03-3116:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-026238 |
| 2025-03-1216:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-010056 |
| 2025-02-2816:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-008696 |
| 2025-02-2816:05 ET | DEF 14A | Proxy statementPeriod 2025-03-31 | 0001213900-25-018759 |
| 2025-01-3116:22 ET | S-1 | Registration statement | 0001213900-25-008855 |
| 2025-01-2909:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-007705 |
| 2025-01-1719:47 ET | SCHEDULE 13D | Ownership report, active investor | 0001493152-25-002859 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 21:01 ET. Listed shows no prices and gives no investment advice.